Abiopharma

Reed Elsevier is a holding company, and a publisher and information provider with principal operations located in North America and Europe. Co. is involved in worldwide scientific, technical and medical publishing and communications businesses; providing legal, tax, regulatory and business information to professional, business and government customers internationally; publishing school textbooks and related instructional and assessment materials, principally in the US, UK, Australia, New Zealand and southern Africa; and providing information and marketing solutions, including trade shows, to business professionals in the US, UK, continental Europe, Australia and Asia.

Additional info from NASDAQ:
RELX, formerly known as Reed Elsevier, is a FTSE 100 diversified information and analytics company. The firm operates across four main areas: scientific, technical, and medical (37% of 2021 sales); risk (34%); legal (22%); and exhibitions (7%). RELX Group has three listings: its primary one in London and two more in New York and Amsterdam.

Additional info from OTC:
Reed Elsevier is a holding company, and a publisher and information provider with principal operations located in North America and Europe. Co. is involved in worldwide scientific, technical and medical publishing and communications businesses; providing legal, tax, regulatory and business information to professional, business and government customers internationally; publishing school textbooks and related instructional and assessment materials, principally in the US, UK, Australia, New Zealand and southern Africa; and providing information and marketing solutions, including trade shows, to business professionals in the US, UK, continental Europe, Australia and Asia.